These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Vaughan Williams class IV antiarrhythmic drugs]. Horie M; Washizuka T; Ikeguchi S; Sasayama S Nihon Rinsho; 1996 Aug; 54(8):2132-7. PubMed ID: 8810788 [TBL] [Abstract][Full Text] [Related]
10. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy. Anderson JL Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring: antiarrhythmic drugs. Campbell TJ; Williams KM Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):21S-34S. PubMed ID: 11564050 [TBL] [Abstract][Full Text] [Related]
12. Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs. Weirich J; Antoni H Basic Res Cardiol; 1998; 93 Suppl 1():125-32. PubMed ID: 9833140 [TBL] [Abstract][Full Text] [Related]
13. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias]. Ravens U Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288 [TBL] [Abstract][Full Text] [Related]
14. New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs. Adams HR J Am Vet Med Assoc; 1986 Sep; 189(5):525-32. PubMed ID: 2875984 [TBL] [Abstract][Full Text] [Related]
15. Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions. Nattel S; Singh BN Am J Cardiol; 1999 Nov; 84(9A):11R-19R. PubMed ID: 10568655 [TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of action of class III anti-arrhythmia agents]. Adamantidis MM Arch Mal Coeur Vaiss; 1995 Jan; 88 Spec No 1():33-40. PubMed ID: 7786143 [TBL] [Abstract][Full Text] [Related]
17. Overview of the clinical pharmacology of antiarrhythmic drugs. Woosley RL; Funck-Brentano C Am J Cardiol; 1988 Jan; 61(2):61A-69A. PubMed ID: 2447771 [TBL] [Abstract][Full Text] [Related]
18. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms. Masotti CS; Pierangeli A Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709 [TBL] [Abstract][Full Text] [Related]
19. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart. Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944 [TBL] [Abstract][Full Text] [Related]
20. [Anti-arrhythmic and cardiodepressive effects of anti-arrhythmia agents]. Scholz H Z Kardiol; 1988; 77 Suppl 5():113-9. PubMed ID: 2464875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]